Showing results (1481-1490 of 5,837) with videos related to
Sort By:
Pageof 584
Drug Design, Development and Therapy|August 1, 2015
Mechanisms underlying probucol-induced hERG-channel deficiencyYuan-Qi Shi, Cai-Chuan Yan, Xiao Zhang, et al.Drug Design, Development and Therapy|August 1, 2015
Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo studyHeba F Salem, Sayed M Ahmed, Ashraf E Hassaballah, et al.Drug Design, Development and Therapy|August 1, 2015
Clinicopathological significance of matrix metalloproteinase-7 protein expression in esophageal cancer: a meta-analysisShuai Miao, Shi-Yao Zhou, Chun-Shan Han, et al.Drug Design, Development and Therapy|August 1, 2015
Design, development, drug-likeness, and molecular docking studies of novel piperidin-4-imine derivatives as antitubercular agentsRajappan Revathi, Ramachandran Venkatesha Perumal, Karkala Sreedhara Ranganath Pai, et al.Drug Design, Development and Therapy|August 1, 2015
Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapyMuhammad Naeem, Moonjeong Choi, Jiafu Cao, et al.Drug Design, Development and Therapy|August 1, 2015
Adjunctive therapies to reduce thrombotic events in patients with a history of myocardial infarction: role of vorapaxarMohamed Farag, Hiten Patel, Diana A GorogDrug Design, Development and Therapy|August 1, 2015
The brain signature of paracetamol in healthy volunteers: a double-blind randomized trialGisèle Pickering, Adrian Kastler, Nicolas Macian, et al.Drug Design, Development and Therapy|August 1, 2015
Dendrimer-coupled sonophoresis-mediated transdermal drug-delivery system for diclofenacBin Huang, Wei-Jiang Dong, Gao-Yi Yang, et al.Drug Design, Development and Therapy|August 15, 2015
Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failureMaria Rosa Ballester, Eulàlia Roig, Ignasi Gich, et al.Drug Design, Development and Therapy|August 15, 2015
High-throughput virtual screening with e-pharmacophore and molecular simulations study in the designing of pancreatic lipase inhibitorsGanesh Kumar Veeramachaneni, K Kranthi Raj, Leela Madhuri Chalasani, et al.Pageof 584